Tuesday, 7 February 2017

Darkest Before the Dawn at Teva

A CEO change at the struggling drug giant marks a value opportunity.

from WSJ.com: Markets http://ift.tt/2kP67ct
via https://ifttt.com/ IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)